drugset / Trial / NCT04138251
Safety, Efficacy Evaluation of Empagliflozin Administration for Neutropenia in Glycogenosis Type 1b and G6PC3 Deficiency
NaSingle-groupOpen-labelTreatment
Summary
Treatment of neutropenia of G6PC3 and Glycogenosis type 1b patients with empagliflozin
Timeline
- Start
- 2019-06-20
- Primary completion
- 2020-06-30
- Completion
- 2020-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Empagliflozin | Small molecule | 10 mg | Oral |